CIK 0000897448 · Accelerated filer
AMARIN CORP PLCUK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 353 1 6699 020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-10-28 | THERO JOHN F President and CEO | Option exercise · Stock Option (Right to Buy) | −11,601 | 363,400 | ||
| 2019-10-07 | THERO JOHN F President and CEO | Grant or award | +1,265,250 | 3,578,560 | ||
| 2019-10-07 | THERO JOHN F President and CEO | Shares withheld for taxes | −497,876 | $14.37 | $7.2M | 3,080,684 |
| 2019-10-07 | Ketchum Steven B Chief Scientific Officer | Grant or award | +199,500 | 553,992 | ||
| 2019-10-07 | Ketchum Steven B Chief Scientific Officer | Shares withheld for taxes | −100,023 | $14.37 | $1.4M | 453,969 |
| 2019-10-07 | Kennedy Joseph T General Counsel | Grant or award | +199,500 | 230,760 | ||
| 2019-10-07 | Kennedy Joseph T General Counsel | Shares withheld for taxes | −105,037 | $14.37 | $1.5M | 125,723 |
| 2019-10-07 | Berg Aaron CHIEF COMMERCIAL OFFICER | Grant or award | +199,500 | 235,851 | ||
| 2019-10-07 | Berg Aaron CHIEF COMMERCIAL OFFICER | Shares withheld for taxes | −102,045 | $14.37 | $1.5M | 133,806 |
| 2019-09-03 | Ekman Lars Director | Option exercise | +13,500 | $5.58 | $75K | 13,500 |
| 2019-09-03 | Ekman Lars Director | Option exercise | +25,845 | $3.06 | $79K | 39,345 |
| 2019-09-03 | Ekman Lars Director | Option exercise | +51,671 | $3.21 | $166K | 91,016 |
| 2019-09-03 | Ekman Lars Director | Sale | −91,016 | $15.01 | $1.4M | 0 |
| 2019-09-03 | Ekman Lars Director | Option exercise · Stock Option (Right to Buy) | −13,500 | 0 | ||
| 2019-09-03 | Ekman Lars Director | Option exercise · Stock Option (Right to Buy) | −25,845 | 0 | ||
| 2019-09-03 | Ekman Lars Director | Option exercise · Stock Option (Right to Buy) | −51,671 | 0 | ||
| 2019-08-21 | THERO JOHN F President and CEO | Option exercise | +24,999 | $2.50 | $62K | 2,313,310 |
| 2019-08-21 | THERO JOHN F President and CEO | Option exercise · Stock Option (Right to Buy) | −24,999 | 375,001 | ||
| 2019-08-21 | THERO JOHN F President and CEO | Option exercise | +49,025 | $2.04 | $100K | 2,181,939 |
| 2019-08-21 | THERO JOHN F President and CEO | Option exercise | +106,372 | $1.02 | $108K | 2,288,311 |
Page 61 of 67 · 1,339 trades